Presentation TCT 2013

Procedural Experience and Outcomes in the CoreValve US Extreme Risk Study

Presenter: Michael Reardon

October 29, 2013

REGISTER for free or LOG IN to view this content

Procedural Experience and Outcomes in the CoreValve US Extreme Risk Study

Aortic Valve

Presentation

TCT 2013

Up Next

Presentation TCT 2013

TCT-38. Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis

Presenter: Michael Haude

October 29, 2013

More slides +

Presentation TCT 2013

Which Patients with Degenerative Mitral Valve Disease Are Appropriate for a Transcatheter Approach?

Presenter: Olaf Franzen

October 29, 2013

Presentation

TAVR vs. Surgery in Intermediate Risk Patients

Presenter: Martin Leon

October 29, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.